Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review

I Monsef, C Doree, EM Wood… - Cochrane Database …, 2020 - cochranelibrary.com
Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality
in patients with viral respiratory diseases, and are currently being investigated in trials as …

[HTML][HTML] Age-related morbidity and mortality among patients with COVID-19

SJ Kang, SI Jung - Infection & chemotherapy, 2020 - ncbi.nlm.nih.gov
Abstract On March 11, 2020, the World Health Organization declared coronavirus disease
(COVID-19), caused by the novel coronavirus severe acute respiratory syndrome …

[HTML][HTML] Digital health equity and COVID-19: the innovation curve cannot reinforce the social gradient of health

A Crawford, E Serhal - Journal of medical Internet research, 2020 - jmir.org
Digital health innovations have been rapidly implemented and scaled to provide solutions to
health delivery challenges posed by the coronavirus disease (COVID-19) pandemic. This …

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

SA SeyedAlinaghi, P Mirzapour, O Dadras… - European journal of …, 2021 - Springer
Abstract Introduction Coronavirus Disease-2019 (SARS-CoV-2) started its devastating
trajectory into a global pandemic in Wuhan, China, in December 2019. Ever since, several …

Analysis of the COVID-19 pandemic: lessons towards a more effective response to public health emergencies

Y Assefa, CF Gilks, S Reid, R van de Pas… - Globalization and …, 2022 - Springer
Abstract Background The pandemic of Coronavirus Disease 2019 (COVID-19) is a timely
reminder of the nature and impact of Public Health Emergencies of International Concern …

The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients

A Daneshkhah, V Agrawal, A Eshein, H Subramanian… - MedRxiv, 2020 - medrxiv.org
Objectives To investigate the possible role of Vitamin D (Vit D) deficiency via unregulated
inflammation in COVID-19 complications and associated mortality. Design The time …

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review

SJ Valk, C Kimber, E Dorando, I Monsef… - Cochrane Database …, 2021 - cochranelibrary.com
Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality
in patients with viral respiratory diseases, and are being investigated as potential therapies …

[HTML][HTML] Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study

BLH Sim, SK Chidambaram, XC Wong… - The Lancet Regional …, 2020 - thelancet.com
Background COVID-19 emerged as a major public health outbreak in late 2019. Malaysia
reported its first imported case on 25th January 2020, and adopted a policy of extensive …

Are dental schools adequately preparing dental students to face outbreaks of infectious diseases such as COVID‐19?

S Ghai - Journal of dental education, 2020 - Wiley Online Library
Abstract The recent 2019‐novel coronavirus (2019‐nCoV, also known as SARS‐CoV‐2)
has caused> 2,622,571 confirmed cases of coronavirus disease 2019 (COVID‐19) in> 185 …

[HTML][HTML] Equal risk, unequal burden? Gender differentials in COVID-19 mortality in India

W Joe, A Kumar, S Rajpal, US Mishra… - Journal of Global …, 2020 - e-jghs.org
Background Early reports on coronavirus disease 2019 (COVID-19) case fatalities in India
suggests that males are at a greater disadvantage than females, but it is unclear whether …